Hjortdal Jesper, Ehlers Niels
Department of Ophthalmology, Aarhus University Hospital, Denmark.
Acta Ophthalmol. 2009 May;87(3):310-4. doi: 10.1111/j.1755-3768.2008.01492.x. Epub 2009 Mar 19.
To compare the outcome of Descemet's stripping endothelial keratoplasty (DSAEK) to that of penetrating keratoplasty (PK) in patients with Fuchs' endothelial dystrophy.
The first 20 patients who underwent DSAEK at the Department of Ophthalmology, Aarhus University Hospital were compared to 20 patients treated with classic PK. Best-corrected visual acuity, subjective spectacle refraction and corneal thickness were registered before surgery and 1, 3, 6 and 12 months after DSAEK surgery; they were also measured before surgery and 12 months and 2-3 years after PK. Endothelial cell density was measured 12 months after surgery in both groups.
Two primary graft failures were observed in the DSAEK group; no failures were seen in the PK group. Best spectacle-corrected visual acuity (BSCVA) at 12 months after surgery was significantly better in the DSAEK group (0.56 +/- 0.04) than in the PK group (0.33 +/- 0.06). At this time, 70% of the DSAEK-treated eyes but only 25% of PK-treated eyes had obtained a BSCVA of 0.5 or better. Two to three years after surgery, BSCVA was 0.5 or better in 55% of PK-treated eyes. Refractive ametropia and astigmatism were significantly smaller in DSAEK-treated eyes than in PK-treated eyes, even after suture removal and arcuate keratotomy. Endothelial cell density (cells/mm2) after 1 year was lower in DSAEK-treated (1.338 +/- 113) than in PK-treated eyes (1.610 +/- 124), but the difference was not statistically significant.
DSAEK seems to be superior to PK in treating Fuchs' endothelial keratoplasty, although primary graft failure may be more common. Visual recovery is faster, and major ametropia and astigmatism is not induced. Long-term follow-up studies are essential to assess whether this conclusion also holds true more than 1 year after surgery.
比较Descemet膜剥除内皮角膜移植术(DSAEK)与穿透性角膜移植术(PK)治疗Fuchs内皮营养不良患者的效果。
将奥胡斯大学医院眼科首批接受DSAEK手术的20例患者与20例接受经典PK手术的患者进行比较。记录手术前以及DSAEK手术后1、3、6和12个月时的最佳矫正视力、主观验光和角膜厚度;同时记录PK手术前、术后12个月以及2 - 3年时的上述指标。两组均在术后12个月测量内皮细胞密度。
DSAEK组观察到2例原发性移植失败;PK组未出现失败病例。DSAEK组术后12个月时的最佳眼镜矫正视力(BSCVA)(0.56±0.04)显著优于PK组(0.33±0.06)。此时,接受DSAEK治疗的眼睛中有70%达到了0.5或更好的BSCVA,而接受PK治疗的眼睛中只有25%达到该水平。术后两到三年,接受PK治疗的眼睛中有55%的BSCVA为0.5或更好。即使在拆线和行弧形角膜切开术后,DSAEK治疗的眼睛的屈光不正和散光也明显小于PK治疗的眼睛。DSAEK治疗的眼睛术后1年时的内皮细胞密度(细胞/mm²)(1.338±113)低于PK治疗的眼睛(1.610±124),但差异无统计学意义。
DSAEK在治疗Fuchs内皮角膜营养不良方面似乎优于PK,尽管原发性移植失败可能更常见。视力恢复更快,且不会引起严重的屈光不正和散光。长期随访研究对于评估该结论在术后1年以上是否仍然成立至关重要。